The Enterprise Value as of December 2025 (TTM) for Estrella Immunopharma, Inc. (ESLA) is 71.57M

According to Estrella Immunopharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 71.57M. This represents a change of 91.07% compared to the average of 37.46M of the last 4 quarters.

Estrella Immunopharma, Inc. (ESLA) Historical Enterprise Value (quarterly & annually)

How has ESLA Enterprise Value performed in the past?

The mean historical Enterprise Value of Estrella Immunopharma, Inc. over the last ten years is 38.36M. The current 71.57M Enterprise Value has changed 18.56% with respect to the historical average. Over the past ten years (40 quarters), ESLA's Enterprise Value was at its highest in in the June 2022 quarter at 351.92M. The Enterprise Value was at its lowest in in the September 2023 quarter at -12006187.96.

Estrella Immunopharma, Inc. (ESLA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Estrella Immunopharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Estrella Immunopharma, Inc. (ESLA) Average Enterprise Value

How has ESLA Enterprise Value performed in the past?

The current Enterprise Value of Estrella Immunopharma, Inc. (ESLA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Estrella Immunopharma, Inc. (ESLA) Enterprise Value vs. Peers

How is ESLA’s Enterprise Value compared to its peers?

Estrella Immunopharma, Inc.’s Enterprise Value is less than eXoZymes, Inc. (121.71M), less than Greenwich LifeSciences, Inc. (118.02M), greater than Atossa Therapeutics, Inc. (40.25M), less than Surrozen, Inc. (73.38M), less than Anebulo Pharmaceuticals, Inc. (87.02M), less than Tevogen Bio Holdings Inc. (85.88M), less than Oncolytics Biotech Inc. (125.73M), greater than Instil Bio, Inc. (69.60M), greater than Tiziana Life Sciences Ltd (-65269000.00), less than Immix Biopharma, Inc. (147.65M),

Build a custom stock screener for Estrella Immunopharma, Inc. (ESLA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Estrella Immunopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Estrella Immunopharma, Inc. (ESLA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Estrella Immunopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.